Table 1.
Cpda | Sequence | Sb | Ic |
---|---|---|---|
1 | DABCYL-RRINR-Glu(EDANS)-NH2 | + | + |
2 | DABCYL-RRINR-OH | + | − |
3 | DABCYL-RRIN-OH | + | − |
4 | DABCYL-RRI-OH | + | − |
5 | DABCYL-RR-OH | − | − |
6 | DABCYL-RRINR-Glu-EDANS | + | + |
7 | DABCYL-RRIN-EDANS | + | + |
8 | DABCYL-RRI-EDANS | + | + |
Compounds 2–5 and DABCYL-Arg-OH have been synthesized and used as LC-MS standards to determine cleavage fragments. Based on retention time and mass detection DABCYL-Arg-OH was one of products in all cleavage mixtures except 5.
Substrate: the vertical line designates that the peptides were cleaved by Pla (LC-MS tested).
Inhibitor: the inhibitory activity of the peptides was determined using functional assay on fibrin plates.